Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine




Disease portal vein thrombosis
Comorbidity C0023890|cirrhosis
Sentences 21
PubMedID- 25845711 Increased risk of portal vein thrombosis in patients with cirrhosis due to nonalcoholic steatohepatitis.
PubMedID- 23810655 The coagulation pattern and the determinants of portal vein thrombosis (pvt), both in patients with and without cirrhosis, are still largely unknown.
PubMedID- 21127694 portal vein thrombosis in a patient with hcv cirrhosis and combined hemophilia a and thrombophilia v leiden.
PubMedID- 25511529 portal vein thrombosis occurs frequently in patients with cirrhosis, but it is unclear whether it is a cause or consequence of decompensation in cirrhosis.
PubMedID- 26080307 Therefore, the indications and effects of anticoagulation therapy for portal vein thrombosis in patients with cirrhosis remain uncertain.
PubMedID- 20666991 Background: extrahepatic portal vein thrombosis, not associated with cirrhosis or tumours, is the second most frequent cause of portal hypertension worldwide.
PubMedID- 25701619 Effects of surgical procedures on the occurrence and development of postoperative portal vein thrombosis in patients with cirrhosis complicated by portal hypertension.
PubMedID- 24890816 Procoagulant abnormalities in cirrhosis with portal vein thrombosis.
PubMedID- 19864937 Impact of antithrombin iii concentrates on portal vein thrombosis after splenectomy in patients with liver cirrhosis and hypersplenism.
PubMedID- 22472055 Conclusions: early anticoagulation treatment in cirrhosis patients with portal vein thrombosis and acute variceal bleeding may be safe, tolerated, and effective in cases with positive intra-thrombus enhancement on contrast ultrasonography.
PubMedID- 25759969 Advanced cirrhosis combined with portal vein thrombosis: a randomized trial of ps versus endoscopic band ligation plus propranolol for the prevention of recurrent esophageal variceal bleeding.
PubMedID- 19464131 Conclusion: ceus seems to be the pretty sensitive and specific test for diagnosing malignant portal vein thrombosis in patients with cirrhosis and tumors.
PubMedID- 20932597 Background & aims: data on the management of portal vein thrombosis (pvt) in patients with decompensated cirrhosis are extremely limited, particularly in the cases of the transjugular intrahepatic portosystemic shunt (tips).
PubMedID- 19863496 Background: as current imaging techniques in cirrhosis allow detection of asymptomatic portal vein thrombosis during routine ultrasonography, more patients with cirrhosis are diagnosed with portal vein thrombosis.
PubMedID- 21190093 Other reported cases of malignant portal vein thrombosis have been in patients with underlying hepatoma, cirrhosis, or with intrabiliary hepatocelluar carcinoma.
PubMedID- 21310200 There are indications that the risk for development of portal vein thrombosis in patients with advanced liver cirrhosis might be increased under therapy with thrombopoietin receptor agonists.
PubMedID- 25013680 In the presence of cirrhosis with portal vein thrombosis, liver transplantation can still be done in combination with thrombectomy or use of intervening jump graft.
PubMedID- 24829653 They suggested predisposition to hcc due to integration of hbv genome into host genome during intrauterine life.16 although development of portal vein thrombosis in a patient with cirrhosis can be explained, however the presence of both cirrhosis and hepatocellular carcinoma in a young adult with isolated hbv infection is very unusual.
PubMedID- 19730112 Background: treatment of portal vein thrombosis (pvt) in patients with liver cirrhosis is not well established.
PubMedID- 21054520 Background and aim: we aimed to validate the non-invasive criteria for the characterization of portal vein thrombosis (pvt) in patients with cirrhosis and hepatocellular carcinoma (hcc).
PubMedID- 25013592 Explanted liver pathology had mixed macro- and micro-nodular cirrhosis with portal vein thrombosis.

Page: 1